Status:
COMPLETED
Turmeric and Exercise-Induced Muscle Damage and Oxinflammation
Lead Sponsor:
Appalachian State University
Collaborating Sponsors:
MegaFood
Conditions:
Muscular Injury
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to measure the effect of using a turmeric-based supplement for 2-weeks on muscle damage and soreness that occur in the body after 90-minutes of exercise. Participants will...
Detailed Description
Orientation, Supplementation, and Basic Study Procedures (Visit #1): Participants will first come to the Human Performance Lab (600 Laureate Way, North Carolina Research Campus, Kannapolis, NC) for an...
Eligibility Criteria
Inclusion
- Male or female, ages 18-50 years.
- Non-smoker.
- Body mass index less than 35 kg/m2 (below moderate or severe obesity).
- Not engaged in regular resistance training (less than 3 sessions per week).
- Agree to train normally, maintain weight, and avoid the regular use of large-dose vitamin and mineral supplements, protein supplements, herbs, and medications that influence inflammation and immune function (especially Advil, Motrin, aspirin, and similar anti-inflammatory drugs) for the duration of the study. (You will review your supplement and medication use with the Research Manager during orientation).
- Categorized as "low risk" using the American College of Sports Medicine screening questionnaire.
- Generally healthy and without chronic disease including cardiovascular disease (e.g., heart disease, stroke), cancer, type 1 and 2 diabetes, rheumatoid arthritis.
Exclusion
- Inability to comply with study requirements.
- Engaged in regular resistance training (3 or more sessions per week, on average).
- Body weight below 110 pounds.
- Pregnant or breastfeeding.
- Any other concurrent condition which, in the opinion of the primary investigator (PI), would preclude participation in this study or interfere with compliance.
- Current diagnosis of cardiovascular disease, diabetes, or cancer (except for non-melanoma skin cancer).
- History of allergic reactions to turmeric, devil's claw, boswellia extract, or ginger extract.
Key Trial Info
Start Date :
December 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04765527
Start Date
December 15 2020
End Date
June 15 2021
Last Update
June 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Appalachian State University Human Performance Lab, North Carolina Research Campus
Kannapolis, North Carolina, United States, 28081